您当前的位置：
首页 >
文章列表页 >
SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma
更新时间：2023-05-16

    • SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma

    • Genes & Diseases   Vol. 10, Issue 2, (2023)
    • 作者机构：

      1. Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University,Hubei,Wuhan,China,430071

      2. Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University,Hubei,Wuhan,China,430071

      3. Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University,Hubei,Wuhan,China,430071

      4. Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University,Hubei,Wuhan,China,430071

      5. Department of Biological Repositories, Zhongnan Hospital of Wuhan University,Hubei,Wuhan,China,430071

    • DOI：10.1016/j.gendis.2022.02.016    

      CLC：

    • Published：2023，

      Published Online：1 March 2023，

    扫 描 看 全 文

  • Zihang Zeng, Yanping Gao, Jiali Li, et al. SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma. [J]. Genes & Diseases 10(2).(2023) DOI： 10.1016/j.gendis.2022.02.016.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0